- Filed
- Jun 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Jun 4, 2026 | 17.93M sh |
| Shares Diluted | Q3 2026 · Apr 30, 2026 | 17.93M sh |
| Shares Diluted | Q3 2026 · Apr 30, 2026 | 17.19M sh |
| Shares Diluted | Q3 2026 · Apr 30, 2025 | 16.28M sh |
| Shares Diluted | Q3 2026 · Apr 30, 2025 | 13.54M sh |
| Dividends Paid | Q3 2026 · Apr 30, 2026 | $15.42K |
| Dividends Paid | Q3 2026 · Jul 8, 2025 | $35.62K |
| Dividends Paid | Q3 2026 · Apr 30, 2025 | $0 |
| Capex | Q3 2026 · Apr 30, 2026 | $0 |
| Capex | Q3 2026 · Apr 30, 2025 | $89.87K |
| Operating Cash Flow | Q3 2026 · Apr 30, 2026 | −$56.11K |
| Operating Cash Flow | Q3 2026 · Apr 30, 2025 | −$644.04K |
| Stockholders Equity | Q3 2026 · Apr 30, 2026 | −$30.54K |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | −$7.28K |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | −$27.67K |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | $4.47K |
| Stockholders Equity restated | Q3 2026 · Apr 30, 2025 | $2.66M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | $2.72M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | $1.09M |
| Stockholders Equity restated | Q3 2026 · Jul 31, 2024 | $1.16M |
| Current Liabilities | Q3 2026 · Apr 30, 2026 | $69.63K |
| Current Liabilities | Q3 2026 · Jul 31, 2025 | $38.34K |
| Total Liabilities | Q3 2026 · Apr 30, 2026 | $419.63K |
| Total Liabilities | Q3 2026 · Jul 31, 2025 | $38.34K |
| Current Assets | Q3 2026 · Apr 30, 2026 | $39.09K |
| Current Assets | Q3 2026 · Jul 31, 2025 | $42.81K |
| Total Assets | Q3 2026 · Apr 30, 2026 | $389.09K |
| Total Assets | Q3 2026 · Jul 31, 2025 | $42.81K |
| Eps Diluted | Q3 2026 · Apr 30, 2026 | $0.00 |
| Eps Diluted | Q3 2026 · Apr 30, 2026 | −$0.01 |
| Eps Diluted | Q3 2026 · Apr 30, 2025 | $0.00 |
| Eps Diluted | Q3 2026 · Apr 30, 2025 | −$0.02 |
| Sga Expense | Q3 2026 · Apr 30, 2026 | $153 |
| Sga Expense | Q3 2026 · Apr 30, 2026 | $3.2K |
| Sga Expense restated | Q3 2026 · Apr 30, 2025 | $1.59K |
| Sga Expense restated | Q3 2026 · Apr 30, 2025 | $2.27K |
| Net Income | Q3 2026 · Apr 30, 2026 | −$23.27K |
| Net Income | Q3 2026 · Apr 30, 2026 | −$117.51K |
| Net Income restated | Q3 2026 · Apr 30, 2025 | −$62.27K |
| Net Income restated | Q3 2026 · Apr 30, 2025 | −$215.05K |
| Operating Income | Q3 2026 · Apr 30, 2026 | −$15.05K |
| Operating Income | Q3 2026 · Apr 30, 2026 | −$100.79K |
| Operating Income restated | Q3 2026 · Apr 30, 2025 | −$19.53K |
| Operating Income restated | Q3 2026 · Apr 30, 2025 | −$96.79K |
| Revenue | Q3 2026 · Apr 30, 2026 | $0 |
| Revenue | Q3 2026 · Apr 30, 2026 | $0 |
| Revenue restated | Q3 2026 · Apr 30, 2025 | $0 |
| Revenue restated | Q3 2026 · Apr 30, 2025 | $0 |